Molecular features evaluation of metastatic foci as the basis for metastatic breast cancer treatment personalization. Is there a place of CDK4/6-inhibitors in late-line therapy after chemotherapeutic regimens?

The problem of metastatic breast cancer treatment is linked with clonal selection both in the process of tumor evolution and under the  influence of  previous treatment. The  analysis of  metastatic niche microenvironment and the  molecular genetic features become essential for treatment individuali...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	A. I. Stukan, A. Y. Goryainova, E. V. Lymar, S. V. Sharov, V. V. Antipova
Format:	Artigo
Sprache:	Russo
Veröffentlicht:	Remedium Group LLC 2021-12-01
Schriftenreihe:	Медицинский совет
Schlagworte:	receptor status metastatic focus discordance premetastatic niche breast cancer combined hormonal therapy cdk4/6 inhibitors
Online-Zugang:	https://www.med-sovet.pro/jour/article/view/6580
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!